Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

0796 AIO BREATHE for OSA: Matching Airflow to Oxygen Demand with CONNECTED-ARC-OF-MOTION, AI-PREDICTIVE Oral Device Geometry and ON-DEMAND-AIRFLOW Delivery

View through CrossRef
Abstract Introduction AIOMEGA’s FDA-cleared (K233754) AIO BREATHE™ is a unique Total Antero-Vertical Mandibular-Lingual Repositioning Device (TAVMLRD™) from patented inventions by the first author. Its flanges display unique geometry that result in CONNECTED-ARC-OF-MOTION™ that provides REVIVE ON-DEMAND-AIRFLOW™, a method of calibrating incremental reduction in airflow resistance by increasing the SMCA (Smallest Cross-sectional Area) of the collapsible part of the airway during sleep or wake. Methods Subjects with suspected OSA underwent pretreatment and post-treatment clinical examination with ESS, Ghuge Fatigue Scale. Pre-RX and post-RX Home Sleep Studies were performed. AI-Predictive device flange geometry specified production of AIO BREATHE for entire group and forecasted post-RX AHI/LSAT. Pre-AHI, Pre-LSAT, Post-AHI and Post-LSAT were tabulated, univariate and multi-variate regression analysis were performed. Results Goup included mild, moderate and severe OSA. N = 50. Mean pre-RX AHI was 20.07, AHI range was 9-38, 1 Std. dev was 11.01. Mean pre-LSAT was 84.60%, LSAT range was 78% - 91% with mean of 84.60%. Mean Post-RX AHI was 2.13, AHI range was 0 – 4.5 with 1 Std. Dev of 1.46. Mean Post RX-LSAT was 92.4%, LSAT range was 90% - 96%. Ability to predict Post-RX AHI with AI-driven algorithms was 98.5% with p-value of 0.065 and T-stat of 2.141. Lower 95th% -1.773 and upper 95th% 2.468. Ability to predict Post-RX LSAT with AI-driven Algorithms was 99% with p-value of 0.15, adjusted R square of 0.131. Lower 95th% -0.095 and upper 95th% 0.472. Conclusion AIO BREATHE effectively treated all severities of OSA (up to AHI 38 and LSAT 78%) in this group. All participants experienced improvement in clinical symptoms. HSAT proved effective therapy (AHI < 5, LSAT >90%) with AI-predictive modeling of AIO BREATHE geometry. Design geometry reduced therapeutic uncertainty, minimized side effects like TMJ or dental movement and built dentist/physician/patient trust. AIOMEGA’s AI-predictive algorithms are device geometry-specific. Support (if any) AIOMEGA LLC.
Oxford University Press (OUP)
Title: 0796 AIO BREATHE for OSA: Matching Airflow to Oxygen Demand with CONNECTED-ARC-OF-MOTION, AI-PREDICTIVE Oral Device Geometry and ON-DEMAND-AIRFLOW Delivery
Description:
Abstract Introduction AIOMEGA’s FDA-cleared (K233754) AIO BREATHE™ is a unique Total Antero-Vertical Mandibular-Lingual Repositioning Device (TAVMLRD™) from patented inventions by the first author.
Its flanges display unique geometry that result in CONNECTED-ARC-OF-MOTION™ that provides REVIVE ON-DEMAND-AIRFLOW™, a method of calibrating incremental reduction in airflow resistance by increasing the SMCA (Smallest Cross-sectional Area) of the collapsible part of the airway during sleep or wake.
Methods Subjects with suspected OSA underwent pretreatment and post-treatment clinical examination with ESS, Ghuge Fatigue Scale.
Pre-RX and post-RX Home Sleep Studies were performed.
AI-Predictive device flange geometry specified production of AIO BREATHE for entire group and forecasted post-RX AHI/LSAT.
Pre-AHI, Pre-LSAT, Post-AHI and Post-LSAT were tabulated, univariate and multi-variate regression analysis were performed.
Results Goup included mild, moderate and severe OSA.
N = 50.
Mean pre-RX AHI was 20.
07, AHI range was 9-38, 1 Std.
dev was 11.
01.
Mean pre-LSAT was 84.
60%, LSAT range was 78% - 91% with mean of 84.
60%.
Mean Post-RX AHI was 2.
13, AHI range was 0 – 4.
5 with 1 Std.
Dev of 1.
46.
Mean Post RX-LSAT was 92.
4%, LSAT range was 90% - 96%.
Ability to predict Post-RX AHI with AI-driven algorithms was 98.
5% with p-value of 0.
065 and T-stat of 2.
141.
Lower 95th% -1.
773 and upper 95th% 2.
468.
Ability to predict Post-RX LSAT with AI-driven Algorithms was 99% with p-value of 0.
15, adjusted R square of 0.
131.
Lower 95th% -0.
095 and upper 95th% 0.
472.
Conclusion AIO BREATHE effectively treated all severities of OSA (up to AHI 38 and LSAT 78%) in this group.
All participants experienced improvement in clinical symptoms.
HSAT proved effective therapy (AHI < 5, LSAT >90%) with AI-predictive modeling of AIO BREATHE geometry.
Design geometry reduced therapeutic uncertainty, minimized side effects like TMJ or dental movement and built dentist/physician/patient trust.
AIOMEGA’s AI-predictive algorithms are device geometry-specific.
Support (if any) AIOMEGA LLC.

Related Results

Obstructive Sleep Apnea is an Independent Risk Factor for Pulmonary Nodules
Obstructive Sleep Apnea is an Independent Risk Factor for Pulmonary Nodules
Abstract Background Although previous studies have suggested a potential connection between OSA and lung cancer, the relationship between OSA and pulmonary nodules remains...
A study on the prevalence of RLS in OSA and the consequences of co-occurrence
A study on the prevalence of RLS in OSA and the consequences of co-occurrence
ABSTRACT Background: Restless leg syndrome (RLS) is common among patients with obstructive sleep apnoea (OSA) but the prognostic importance of th...
Back‐arc rifting in the Izu‐Bonin Island Arc: Structural evolution of Hachijo and Aoga Shima Rifts
Back‐arc rifting in the Izu‐Bonin Island Arc: Structural evolution of Hachijo and Aoga Shima Rifts
Abstract Multi‐ and single‐channel seismic profiles are used to investigate the structural evolution of back‐arc rifting in the intra‐oceanic Izu‐Bonin Arc. Hachijo and Aoga ...
P096 Prevalence and risk factors of OSA in people with sarcoidosis
P096 Prevalence and risk factors of OSA in people with sarcoidosis
Abstract Background Emerging evidence suggests a link between sarcoidosis and an increased risk of developing obstructive sleep ...

Back to Top